283 related articles for article (PubMed ID: 11403419)
1. Chronic effects of ACE-inhibition (quinapril) and angiotensin-II-type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei of rats with experimental myocardial infarction.
Hu K; Bahner U; Gaudron P; Palkovits M; Ring M; Fehle A; Kruse B; Ertl G
Basic Res Cardiol; 2001; 96(3):258-66. PubMed ID: 11403419
[TBL] [Abstract][Full Text] [Related]
2. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
3. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
4. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
Magga J; Kalliovalkama J; Romppanen H; Vuolteenaho O; Pörsti I; Kähönen M; Tolvanen JP; Ruskoaho H
J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466
[TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse.
Patten RD; Aronovitz MJ; Einstein M; Lambert M; Pandian NG; Mendelsohn ME; Konstam MA
Clin Sci (Lond); 2003 Feb; 104(2):109-18. PubMed ID: 12546633
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with angiotensin converting enzyme inhibition and AT1 receptor inhibitor on ventricular remodeling after myocardial infarction in rats.
Zornoff LA; Paiva SA; Matsubara BB; Matsubara LS; Spadaro J
J Cardiovasc Pharmacol Ther; 2000 Jul; 5(3):203-9. PubMed ID: 11150409
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure.
Kawai H; Stevens SY; Liang CS
Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H3012-9. PubMed ID: 11087259
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
Teisman AC; Pinto YM; Buikema H; Flesch M; Böhm M; Paul M; van Gilst WH
J Hypertens; 1998 Dec; 16(12 Pt 1):1759-65. PubMed ID: 9869009
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide.
Sata N; Tanaka Y; Suzuki S; Kamimura R; Mifune H; Nakamura K; Miyahara K; Arima T
Circ J; 2003 Dec; 67(12):1053-8. PubMed ID: 14639023
[TBL] [Abstract][Full Text] [Related]
11. Chronic AT1 receptor blockade and angiotensin-converting enzyme (ACE) inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival.
Bastien NR; Juneau AV; Ouellette J; Lambert C
Cardiovasc Res; 1999 Jul; 43(1):77-85. PubMed ID: 10536692
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
Stauss HM; Zhu YC; Redlich T; Adamiak D; Mott A; Kregel KC; Unger T
J Cardiovasc Risk; 1994 Oct; 1(3):255-62. PubMed ID: 7621306
[TBL] [Abstract][Full Text] [Related]
14. AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats.
Walther T; Siems WE; Hauke D; Spillmann F; Dendorfer A; Krause W; Schultheiss HP; Tschöpe C
FASEB J; 2002 Aug; 16(10):1237-41. PubMed ID: 12153991
[TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
Benetos A; Levy BI; Lacolley P; Taillard F; Duriez M; Safar ME
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3196-201. PubMed ID: 9409311
[TBL] [Abstract][Full Text] [Related]
16. Chronic ACE inhibition by quinapril modulates central vasopressinergic system.
Muders F; Elsner D; Jandeleit K; Bahner U; Kromer EP; Kirst I; Riegger GA; Palkovits M
Cardiovasc Res; 1997 Jun; 34(3):575-81. PubMed ID: 9231041
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2-receptor expression and IP3 receptor and PKCepsilon proteins.
Xu Y; Menon V; Jugdutt BI
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):184-95. PubMed ID: 11967812
[TBL] [Abstract][Full Text] [Related]
19. Preservation of left ventricular mechanical function and energy metabolism in rats after myocardial infarction by the angiotensin-converting enzyme inhibitor quinapril.
Horn M; Neubauer S; Frantz S; Hugel S; Hu K; Gaudron P; Schnackerz K; Ertl G
J Cardiovasc Pharmacol; 1996 Feb; 27(2):201-10. PubMed ID: 8720418
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.
Sun YP; Zhu BQ; Browne AE; Pulukurthy S; Chou TM; Sudhir K; Glantz SA; Deedwania PC; Chatterjee K; Parmley WW
J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):175-81. PubMed ID: 11509924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
